NPS PHARMA ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of NPS …


Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating whether members of the board of directors of NPS Pharmaceuticals, Inc. (NPSP) breached their fiduciary duties in connection with the planned merger of the Company with Shire plc. NPS Pharma is a biopharmaceutical company, engaged in the development of therapeutic products in the United States.

On January 11, 2015, NPS Pharma and Shire announced that they had entered into a definitive merger agreement. Under the terms of the agreement, stockholders of NPS Pharma will receive $46.00 per share in cash. The transaction values NPS Pharma at approximately $5.2 billion.

The investigation concerns whether NPS Pharma’s board failed to satisfy their duties to the Company’s shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for the Company’s shares of common stock. Nationally recognized Johnson & Weaver, which focuses its practice on shareholder rights, is investigating whether the proposed deal price represents adequate consideration, especially given NPS Pharma’s recent success and promise of future growth. Moreover, one Wall Street analyst has a $48.00 price target on the stock which is more than the $46.00 offer price.

If you are an NPS Pharma shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker ( by email or by phone at 619-814-4471. If emailing, please include a phone number where you can be reached.

About Johnson & Weaver, LLP:

Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes.

Source Article from
NPS PHARMA ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of NPS …
pharma – Yahoo News Search Results
pharma – Yahoo News Search Results


メールアドレスが公開されることはありません。 * が付いている欄は必須項目です

次のHTML タグと属性が使えます: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>